Tenon Medical, Inc. (NASDAQ:TNON) Short Interest Update

by · The Cerbat Gem

Tenon Medical, Inc. (NASDAQ:TNON – Get Free Report) was the recipient of a large decline in short interest in October. As of October 15th, there was short interest totalling 39,800 shares, a decline of 29.2% from the September 30th total of 56,200 shares. Currently, 7.0% of the company’s stock are short sold. Based on an average trading volume of 2,110,000 shares, the short-interest ratio is presently 0.0 days.

Tenon Medical Price Performance

Shares of TNON remained flat at $3.62 during midday trading on Monday. The stock had a trading volume of 191,531 shares, compared to its average volume of 673,338. The firm has a market cap of $1.85 million, a PE ratio of -0.10 and a beta of 2.19. Tenon Medical has a 12-month low of $2.80 and a 12-month high of $37.60. The company’s 50-day moving average is $3.32 and its two-hundred day moving average is $1.62.

Tenon Medical (NASDAQ:TNON – Get Free Report) last released its quarterly earnings results on Tuesday, August 13th. The company reported ($1.02) EPS for the quarter. The business had revenue of $0.90 million during the quarter. Tenon Medical had a negative net margin of 411.27% and a negative return on equity of 4,819.46%.

Wall Street Analyst Weigh In

Separately, Benchmark reaffirmed a “speculative buy” rating and issued a $3.00 price objective on shares of Tenon Medical in a research report on Wednesday, August 14th.

Read Our Latest Research Report on TNON

About Tenon Medical

(Get Free Report)

Tenon Medical, Inc, a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints.

Recommended Stories